3D Printing of Core–Shell Capsule Composites for Post‐Reactive and Damage Sensing Applications
Source abstract
Abstract
Abstract 3D printing of multicomponent materials as an advantageous method over traditional mold casting methods is demonstrated, developing small core–shell capsule composites fabricated by a two‐step 3D printing process. Using a two‐print‐head system (fused deposition modeling extruder and a liquid inkjet print head), micro‐sized capsules are manufactured in sizes ranging from 100 to 800 µm. The thermoplastic polymer poly(ε‐caprolactone) (PCL) is chosen as matrix/shell material due to its optimal interaction with the embedded hydrophobic liquids. First, the core–shell capsules are printed with model liquids and pure PCL to optimize the printing parameters and to ensure fully enclosed capsules inside the polymer. As a proof of concept, novel “click” reaction systems, used in self‐healing and stress‐detection applications, are manufactured in which PCL composites with nano‐ and micro‐fillers are combined with reactive, encapsulated liquids. The so generated 3D printed core–shell capsule composite can be used for post‐printing reactions and damage sensing when combined with a fluorogenic dye.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Additive Manufacturing and 3D Printing Technologies · 3D Printing in Biomedical Research · Advanced Sensor and Energy Harvesting Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Macromolecular Chemistry Division of Technical and Macromolecular Chemistry Institute of Chemistry Faculty of Natural Sciences II (Chemistry, Physics and Mathematics) Martin Luther University Halle‐Wittenberg von‐Danckelmann‐Platz 4 Halle D‐06120 Germany
Funding
Deutsche Forschungsgemeinschaft · European Commission
References (56)
Show source-provided references
1. Kamaljit S. B. · Rapid Prototyping J. · 2016 · 22 · 28110.1108/RPJ-04-2014-0048 ↗
2. 10.1007/s40436-014-0097-710.1007/s40436-014-0097-7 ↗
3. Crump S. · 1991 · 53
4. Crump S. · 1991 · 358
5. 10.1016/j.compositesb.2016.11.03410.1016/j.compositesb.2016.11.034 ↗
6. 10.1002/admt.20190078410.1002/admt.201900784 ↗
7. 10.1002/admt.20190027510.1002/admt.201900275 ↗
8. 10.1002/admt.20190045210.1002/admt.201900452 ↗
9. 10.1002/admt.20180071310.1002/admt.201800713 ↗
10. 10.1002/admt.20190011810.1002/admt.201900118 ↗
11. 10.1016/j.solmat.2019.10994510.1016/j.solmat.2019.109945 ↗
12. 10.1016/j.solmat.2019.11027910.1016/j.solmat.2019.110279 ↗
13. 10.1088/0031-8949/85/05/05580610.1088/0031-8949/85/05/055806 ↗
14. 10.1016/j.jpowsour.2019.22714910.1016/j.jpowsour.2019.227149 ↗
15. 10.1016/j.jddst.2017.06.00810.1016/j.jddst.2017.06.008 ↗
16. 10.1016/j.ejps.2018.04.02010.1016/j.ejps.2018.04.020 ↗
17. 10.1016/j.jconrel.2015.09.02810.1016/j.jconrel.2015.09.028 ↗
18. 10.1002/admt.20190042710.1002/admt.201900427 ↗
19. 10.1007/s11095-016-2083-110.1007/s11095-016-2083-1 ↗
20. 10.1016/j.jddst.2015.07.01610.1016/j.jddst.2015.07.016 ↗
21. 10.1016/j.jconrel.2017.10.00810.1016/j.jconrel.2017.10.008 ↗
22. 10.1208/s12249-018-1029-910.1208/s12249-018-1029-9 ↗
23. 10.1016/j.ijpharm.2019.11858110.1016/j.ijpharm.2019.118581 ↗
24. 10.1016/j.ejps.2018.03.01010.1016/j.ejps.2018.03.010 ↗
25. 10.1021/acs.molpharmaceut.5b0051010.1021/acs.molpharmaceut.5b00510 ↗
26. 10.1016/j.ijpharm.2015.07.06710.1016/j.ijpharm.2015.07.067 ↗
27. 10.1016/j.ijpharm.2018.08.05510.1016/j.ijpharm.2018.08.055 ↗
28. Eleftheriadis G. K. · Pharm. Dev. Technol. · 2020 · 25 · 51710.1080/10837450.2019.1711396 ↗
29. 10.1007/s11095-016-2073-310.1007/s11095-016-2073-3 ↗
30. Chen D. · AAPS PharmSciTech · 2020 · 21 · 610.1208/s12249-019-1521-x ↗
31. 10.1016/j.biomaterials.2007.05.01810.1016/j.biomaterials.2007.05.018 ↗
32. 10.1016/j.biomaterials.2011.01.03610.1016/j.biomaterials.2011.01.036 ↗
33. 10.1016/j.biomaterials.2011.07.02510.1016/j.biomaterials.2011.07.025 ↗
34. 10.1016/j.biomaterials.2010.12.00510.1016/j.biomaterials.2010.12.005 ↗
35. 10.1021/acs.nanolett.5b0168810.1021/acs.nanolett.5b01688 ↗
36. 10.1016/j.ijpharm.2017.05.07410.1016/j.ijpharm.2017.05.074 ↗
37. 10.1002/marc.20160046610.1002/marc.201600466 ↗
38. 10.1039/C4CC07774A10.1039/C4CC07774A ↗
39. 10.1016/j.polymer.2015.10.01310.1016/j.polymer.2015.10.013 ↗
40. 10.3390/polym1001001710.3390/polym10010017 ↗
41. 10.3109/0265204030917808310.3109/02652040309178083 ↗
42. 10.3109/0265204890901989810.3109/02652048909019898 ↗
43. 10.1016/j.jcis.2009.11.03610.1016/j.jcis.2009.11.036 ↗
44. 10.1002/smll.20120053010.1002/smll.201200530 ↗
45. 10.1002/macp.20130055810.1002/macp.201300558 ↗
46. 10.1002/marc.20190046710.1002/marc.201900467 ↗
47. 10.1016/S0032-3861(99)00636-910.1016/S0032-3861(99)00636-9 ↗
48. 10.1016/j.matdes.2019.10783910.1016/j.matdes.2019.107839 ↗
49. 10.1002/marc.20190035910.1002/marc.201900359 ↗
50. 10.1021/ed082p183310.1021/ed082p1833 ↗
51. 10.1021/cr078347910.1021/cr0783479 ↗
52. 10.1021/ja054114s10.1021/ja054114s ↗
53. 10.1002/adma.20140180410.1002/adma.201401804 ↗
54. 10.1021/ja049684r10.1021/ja049684r ↗
55. 10.1039/B901975H10.1039/B901975H ↗
56. 10.1039/C6CC05390D10.1039/C6CC05390D ↗